Khurram Jamil, Chief Officer of Galectin Therapeutics GALT, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $1.4M. The latest trade was on 06/29.

KJ

KJ

Khurram Jamil

Chief Medical Officer

Company

Galectin Therapeutics GALT

First filing

24/08/05

Trades

49 trades

Buys / sales

0 / 17

12-month net buying

−$1.4M

Last trade

06/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	06/26–06/29	06/30	52,037 sh3 trades	$5.04avg.	$262,083.68	−100.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	06/23	06/25	7,557 sh	$3.14	$23,728.98	−100.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	05/26	05/28	568 sh	$3.10	$1,760.8	−100.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	01/02–01/06	01/06	60,000 sh3 trades	$3.88avg.	$232,555	−100.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	25/12/31	01/05	8,125 sh	$4.07	$33,068.75	−100.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	25/12/17	25/12/19	19,442 sh3 trades	$7.04avg.	$136,871.68	−100.0%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	25/11/13	25/11/14	121,117 sh4 trades	$5.47avg.	$662,509.99	−96.4%
Galectin TherapeuticsGALT	Open-market sale10b5-1 plan	24/12/23	24/12/26	13,654 sh	$0.88	$12,015.52	−34.1%